Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Polish

Breadcrumb

  1. Home
  2. Skin under triple influences : gut, brain, skin microbiota
  3. Skin diseases associated with a dysbiosis
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Skin under triple influences : gut, brain, skin microbiota
  3. Skin diseases associated with a dysbiosis
Dermatology

Skin diseases associated with a dysbiosis

Skin health
Dermatology

The skin microbiota is a dynamic system in which microorganisms constantly compete to survive. Sometimes this balance breaks down, commensal bacteria become opportunistic pathogens1,4 and a dysbiosis results: it is a common feature in skin diseases (acne, psoriasis, dermatitis, etc.) and other non-pathological skin conditions (irritation, wounds, odors). However, it is not yet known whether dysbiosis is a cause or effect.2

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Created 22 April 2021
Updated 25 November 2021

Acne, psoriasis, rosacea... Many skin diseases are associated with a dysbiosis. This may have diagnostic or predictive value or even open up novel therapeutic approaches.

Skin cancer

Pathophysiology:

in many cutaneous neoplasms, dysbiosis appears to be involved in carcinogenesis.9,10,11,12 Conversely, a healthy microbiota may inhibit the development of tumors by regulating the immune system and controlling inflammation.

Role of the microbiota:

  • S. aureus, Streptococcus pyogenes, Pseudomonas aeruginosa, the β-human papillomavirus, the Epstein Barr virus and Malassezia or Candida fungi may induce a state of chronic inflammation, leading to cancer;16
  • link between S. aureus infection and severity of cutaneous T cell lymphoma.12

Psoriasis

Pathophysiology:

multifactorial immune-mediated disease, involving genetic factors, immune system disturbances and environmental triggers.13

Prevalence:

affects 2%-3% of the population, often appearing between 15 and 20 years of age11 with two common peaks of incidence (20-30 years of age and 50-60 years of age).13.

Role of the microbiota:

  • psoriasis patients see an alteration in the composition of their skin microbiota and a loss of microbial diversity11, which affects not only the lesions, but the skin microbiota as a whole.11
  • microorganisms associated with the disease still not clearly identified1,11, with numerous contradictory data. However, S. aureus thought to be more abundant and to participate in inflammation (by increasing the response of Th17 cells, which release pro-inflammatory cytokines);11
  • often associated with gut dysbiosis.14

Acne

Pathophysiology:

multifactorial chronic inflammatory disease involving hyperseborrhea, abnormal keratinization of follicular ducts and a dysbiosis of the skin microbiota associated with a predominance of virulent C. acnes phylotypes.9

Prevalence:

8th most common skin disease, affecting 9.38% of the world’s population (all ages), with higher prevalence in adolescents, reaching 35%-100% in some countries.10

Role of the microbiota:

  • loss of balance between the different C. acnes phylotypes (the more virulent phylotype IA1 becomes do minant and induces inflammation by activating the innate immune system);9
  • loss of reciprocal control between C. acnes (maintains acidic pH, inhibits the development of S. epidermidis) and S. epidermidis (anti-inflammatory activity, limits the proliferation of C. acnes);9
  • suspected secondary pro-inflammatory role (folliculitis) of opportunistic fungal species of the pilosebaceous apparatus (Malassezia and possibly Candida);11
  • additional effect of diet on acne severity (interaction with gut microbiota).9

Atopic dermatitis (eczema)

Pathophysiology:

chronic inflammatory skin disease with a strong genetic component involving a disruption of the skin barrier and immune system (inflammatory Th2 cells), resulting in increased susceptibility to infections and allergens.11,15

Prevalence:

up to 20% of infants and 3% of adults worldwide11, and up to 10% of adults in developed countries.14

Role of the microbiota:

  • patients see a loss of diversity in the skin microbiota11,12, both in lesions and healthy areas;
  • increase in content of staphylococci, with a proliferation of S. aureus linked to a lower production of antimicrobial peptides by keratinocytes via the influence of Th2 cells.15 Increased presence of S. epidermidis in less severe forms;12
  • a higher density of colonization with S. aureus correlated with more inflammation and increased disease severity.11

Seborrheic Dermatitis (SD) and Dandruff

Pathophysiology:

chronic skin disease involving a complex interaction between the Malassezia fungus, keratinocytes, and the inflammatory response induced by an altered lipid composition in the skin.12,18

Prevalence:

three peaks of incidence (early childhood, adolescence and from the age of 50 onwards). Half of adult population thought to be affected by DS and dandruff.11,18

Role of the microbiota:

  • hydrolysis by Malassezia of skin lipids into free fatty acids that trigger an inflammatory response;16
  • increased presence of Malassezia species, with M. restricta,M. globose and M. furfur the most commonly associated with seborrheic dermatitis. The first two species are the most virulent (they produce irritating oleic acids, leading to IL-8 and IL-17 activation);17
  • Actinetobacter, Staphylococcus and Streptococcus dominate microbiota in the lesions;11
  • correlation between disease severity and decreased bacterial diversity; no correlation with Malassezia abundance.12

Rosacea

Pathophysiology:

chronic inflammatory disease whose pathophysiology is not fully understood. Factors include neurovascular reactivity, genetic susceptibility, dysfunction of the innate immune responses, and comorbid gastrointestinal conditions.17

Prevalence:

between 0.9% and 10% of the population in the US and Europe.11

Role of the microbiota:

  • Demodex folliculorum (a sebaceous gland mite) stimulates the production of inflammatory peptides and cellular growth factors. This mite may also carry Bacillus oleronius, a pro-inflammatory bacterium;11
  • a variant of S. epidermidis, more virulent than the commensal bacterium, also thought to be involved;11
  • often associated with a gut dysbiosis.18
Sources

1 Ederveen THA, Smits JPH, Boekhorst J et al. Skin microbiota in health and disease: From sequencing to biology. J Dermatol. 2020 Oct;47(10):1110-1118.

2 Egert M, Simmering R, Riedel CU. The Association of the Skin Microbiota With Health, Immunity, and Disease. Clin Pharmacol Ther. 2017 Jul;102(1):62-69.

9 Dréno B, Dagnelie MA, Khammari A, et al. The Skin Microbiome: A New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):18-24.

10 Heng, A.H.S., Chew, F.T. Systematic review of the epidemiology of acne vulgaris. Sci Rep 10, 5754 (2020). https://doi.org/10.1038/s41598-020-62715-3.

11 Ellis SR, Nguyen M, Vaughn AR, et al. The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions. Microorganisms. 2019;7(11):550.

12 Yu Y, Dunaway S, Champer J, et al. Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2020;182(1):39-46.

13 Rigon RB, de Freitas ACP, Bicas JL, et al. Skin microbiota as a therapeutic target for psoriasis treatment: Trends and perspectives. J Cosmet Dermatol. 2021;20(4):1066-1072.

14 Szántó M, Dózsa A, Antal D et al. Targeting the gut-skin axis-Probiotics as new tools for skin disorder management? Exp Dermatol. 2019 Nov;28(11):1210-1218.

15 Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020 Aug 1;396(10247):345-360.

16 Squarzanti DF, Zavattaro E, Pizzimenti S et al. Non-Melanoma Skin Cancer: news from microbiota research. Crit Rev Microbiol. 2020;46(4):433-449.

17 Tutka K, Żychowska M, Reich A. Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea-A Systematic Review of the Literature. Microorganisms. 2020;8(11):1756.

18 Adalsteinsson JA, Kaushik S, Muzumdar S et al. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29(5):481-489.

Tags
Psoriasis Acne Skin health Rosacea Atopic Dermatitis

en_view en_sources

    Focus
    Skin under triple influences : gut, brain, skin microbiota
    • The skin microbiota
      • A unique set of skin microbiota for each individual
      • Factors affecting the skin microbiota
      • Functions of the microbiota and its interactions with the host
    • Skin diseases associated with a dysbiosis
      • Skin diseases associated with a dysbiosis
      • Non-pathological skin conditions associated with a dysbiosis
    • The gut-skin axis
      • Psoriasis, atopic dermatitis, rosacea: gut-skin axis involved
      • A gut-brain-skin axis?
    • Modulating the skin microbiota
      • Modulating the skin microbiota via topical applications
      • Modulating the skin microbiota with oral solutions
    • Expert opinion
      • Dr. Markus Eger : Probiotics, a complementary therapeutic option
    Created 22 April 2021
    Updated 25 November 2021

    About this article

    To know more about this topic.

    Main topic

    Skin health

    Medical practice

    Dermatology

    Content type

    Dossier detail
    Functions of the microbiota and its interactions with the host
    Non-pathological skin conditions associated with a dysbiosis
    Focus

    Skin under triple influences : gut, brain, skin microbiota

    The skin microbiota

    A unique set of skin microbiota for each individual Factors affecting the skin microbiota Functions of the microbiota and its interactions with the host

    Skin diseases associated with a dysbiosis

    Skin diseases associated with a dysbiosis Non-pathological skin conditions associated with a dysbiosis

    The gut-skin axis

    Psoriasis, atopic dermatitis, rosacea: gut-skin axis involved A gut-brain-skin axis?

    Modulating the skin microbiota

    Modulating the skin microbiota via topical applications Modulating the skin microbiota with oral solutions

    Expert opinion

    Dr. Markus Eger : Probiotics, a complementary therapeutic option
    Dermatology

    Skin Microbiota #17

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more
    Photo: WAAW 2022 (HCPs)
    25.10.2022

    Microbiota at the forefront of antibiotic resistance

    Read the article
    25.10.2022

    Antibiotics: Dr Jekyll and Mr Hyde

    Read the article
    Everything you need to know about Microbiota & Dysbiosis
    27.07.2022

    Everything you need to know about Dysbiosis

    Read the article
    Photo: Antibiotic resistance is a web of several problems (HCPs)
    02.11.2022

    Antibiotic resistance is a web of several problems

    Read the article
    28.10.2021

    6 things you should know about antibiotics

    Read the article
    28.10.2021

    Antimicrobial resistance: a global threat, an international response

    Read the article
    Photo: Dermatite atopique : le mycobiote cutané à la loupe
    12.10.2022

    Atopic dermatitis: skin mycobiota under the microscope

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.03.2023

    Positive impact of running on gut microbiota and adolescent depression

    Read the article
    09.03.2023

    Each subtype of Irritable Bowel Syndrome (IBS) has its own dysbiosis

    Read the article
    Parkinson : le microbiote intestinal, chef d’orchestre des mécanismes pathogéniques ?
    27.02.2023

    Does the gut microbiota orchestrate pathogenic mechanisms in Parkinson’s disease?

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo